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Clinics 
Age and sex 
59 years old female patient. 
Previous history 
No preleukemia. No previous malignancy. No inborn 
condition of note.  
Organomegaly 
No hepatomegaly, no splenomegaly, no enlarged lymph 
nodes, no central nervous system involvement. 
Blood 
WBC: 8.5X 109/l 
HB: 19g/dl 







Rearranged Ig Tcr: - 
Pathology: MPD 
Electron microscopy: - 
Diagnosis: 
Atypical myeloproliferative disease, presenting 
polycythemia and thrombocythemia with 
myelofibrosis. 
Survival 
Date of diagnosis: 09-1988 
Treatment: Hydroxyurea 
 
Partial karyotype (R-banding) at diagnosis presenting the dic(1;15)(p11;p11) associated with trisomy 9. 
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Complete remission: was obtained 
Treatment related death: no 
Phenotype at relapse: AML with unknown phenotype 
due to bone marrow aspiration failure. 
Status: Dead. Last follow up: 12-1997. 
Survival: 111months. 
Karyotype 
Sample: bone marrow 
Culture time: 48 h 
Banding: RHG 
Results: 47,XX,+9,-15,+dic(1;15)(p11;p11)[20] 




Other molecular cytogenetics technics: NA. 




This is an additional MPD case presenting this 
recurrent abnormality, with a 10 years survival. 
However in this case the death is related to the GVH 
disease after allograft. 
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